Latest debt-to-equity ratio
ALX Oncology Holdings Debt-to-equity ratio
Direct answer
ALX Oncology Holdings's debt-to-equity ratio is 8.11%.
The verified market snapshot reports 8.11%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 8.11%
Explore related company data
View ALX Oncology Holdings's market capitalizationView ALX Oncology Holdings's price-to-book ratioView ALX Oncology Holdings's return on equityView ALX Oncology Holdings's dividend yieldView ALX Oncology Holdings's 52-week price rangeView ALX Oncology Holdings's profit marginView all ALX Oncology Holdings key metricsReturn to ALX Oncology Holdings profile